Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 in Partly Controlled Bronchial Asthma
NCT03450434Phase 2Completed
- Sponsor
- PHARMENTERPRISES LLC
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of histamine glutarimide in asthma, sponsored by PHARMENTERPRISES LLC. Started Sep 2016; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03450434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450434.